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Abstract 
 
Antimicrobial resistance is increasing globally. It is estimated that in hospitals around the world 
50% of antimicrobial usage is either unnecessary or inappropriate. The study aimed to explore 
factors surrounding initially prescribed antibiotics and direct medicine related costs in the adult 
Medical Intensive Care Unit (MICU), at Steve Biko Academic Hospital (SBAH). A clinically 
trained pharmacist was included as part of the multi-disciplinary team and evaluated antibiotics 
prescribed after admission. These were considered as the initial course of antibiotics. The 
antimicrobial agents that the patient was admitted with were documented and are referred to as 
³DQWLELRWLFVSULRUWRUHYLHZ´ Just less than half of the patients, 23 (44.2%; n = 52) were initiated 
on antibiotics on the first day of admission to the MICU. The majority of antibiotics 46 (60.5%) 
were prescribed appropriately during the study period.  The total cost of initial antibiotic use for 
the treatment period during the study was R209 140.40, with an average cost of R31 240.77 per 
day for all initial antibiotics. A coordinated effort from the infectious diseases specialist and 
clinical pharmacist within the multi-disciplinary team, assisted in appropriate prescribing of 
antibiotics to patients that were admitted to the MICU.  
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Introduction 
 
Antimicrobial resistance is increasing globally. It is estimated that in hospitals 
around the world 50% of antimicrobial usage is either unnecessary or 
inappropriate (Doron & Davidson, 2011; Martin, Goff, Karam, Dombrowski & 
DeChant, 2009). The timely selection and administration of appropriate 
antimicrobial therapy can significantly impact treatment outcomes, especially in 
patients with severe or life-threatening infections (Drew, 2009). 
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Antimicrobial stewardship is a coordinated effort to ensure the judicious and 
effective use of antimicrobial therapy that includes, but is not limited to the 
appropriate selection, dosing, route of administration, and duration of 
antimicrobial therapy (Martin et al., 2009). The goal of an antimicrobial 
stewardship programme (ASP) is to optimise clinical outcomes while minimizing 
unintended consequences of antimicrobial use, and to reduce health care costs 
without adversely affecting quality of care (Martin et al., 2009). The 
implementation of an ASP can present a challenge due to limited resources and 
other barriers such as lack of physician participation, insufficient diagnostic 
facilities, absence of formal mechanisms of data collection, and lack of 
cooperative strategies from health care workers. Institutional needs and available 
resources should therefore be taken into consideration when planning a strategy 
for ASP implementation. The goal of an ASP is to optimize the use of limited 
resources, overcome barriers to implementation, and improve clinical outcomes 
(Martin et al., 2009). Part of antibiotic stewardship includes the use of appropriate 
biomarkers especially when treating bacterial infection and sepsis. Procalcitonin 
(PCT) have been used as a biomarker to shorten antimicrobial therapy without 
adversely affecting clinical outcomes (Martin et al., 2009). 
 
The Surviving Sepsis Campaign guidelines recommend prompt antimicrobial 
therapy in high-risk patients. Inappropriate antimicrobial therapy for septic shock 
is known to be associated with a five-fold reduction in survival (Dellinger et al., 
2012). Appropriate antibiotic use is of both clinical and economic significance to 
any health care system and should be given adequate attention (Ojeniran, Shouval, 
Miskin, Moses & Shmueli, 2010). Pharmacists play an important role in reducing 
the threat to public health and costs of hospital-acquired antibiotic-resistant 
infections through antimicrobial stewardship (Martin et al., 2009). Antimicrobial 
resistance is increasing; however, antimicrobial drug development is slow. Now, 
more than ever before, antimicrobial stewardship is of the utmost importance as a 
way to optimize the use of antimicrobials, prevent the development of resistance 
and improve patient outcomes (Martin et al., 2009). 
 
In SBAH a need for an ASP was identified by the Head of Infectious Diseases, as 
at the time of the study, an antibiotic policy was not available for the adult MICU.  
The study intended to investigate the use of initially prescribed antimicrobial 
agents in an adult intensive care unit at SBAH as part of an antimicrobial 
stewardship roll out programme. Initially prescribed antibiotics are extremely 
important in high risk patients (ventilator associated pneumonia (VAP), septic 
shock, etc.), and every hour of delay in antibiotic administration after diagnosis, 
is associated with an average decrease in survival of 7.6% (Pong & Bradley, 2005). 
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Methods 
 
Study site 
The study was conducted in the adult MICU at SBAH in Pretoria, situated in the 
Gauteng Province of South Africa. The hospital has 832 beds, including 53 ICU 
beds and 21 high care beds, and it has a theatre complex with 21 operating theatres, 
with 19 operational (Statistical information from SBAH, 2014).  The MICU is a 
9-bed ward and the only ICU in the hospital admitting medical patients. Although 
the MICU has nine beds, at the time of the study it never had more than six beds 
occupied at any given time, because of a shortage of ICU-trained nursing staff. 
 
Study period and design 
This was an operational study with a descriptive and observational design, 
conducted through daily ward rounds over a period of seven months.  
 
Study population and sample 
According to the hospital statistics at the time of the study, the MICU admitted an 
average of 24 patients per month, depending on the staff complement and 
availability of trained ICU staff (Statistical documentation MICU SBAH, 2014). 
All patients newly admitted to the adult MICU at SBAH and who were initiated 
on antimicrobial therapy (received a prescription), were included in the study. This 
resulted in a final sample size of 52 patients, enrolled over the study period of 
seven months.  
 
Data collection and data collection instruments 
For the purposes of the study, antibiotics prescribed and initiated after admission 
to the MICU were considered as the ³LQLWLDOO\ SUHVFULEHG DQWLELRWLFV´. The 
antibiotic agents that patients were admitted with, were documented and are 
referred to as ³DQWLELRWLFVSULRUWRUHYLHZ´ Only antibiotics that were initiated in 
the MICU were included in the study for review and evaluation. Direct costs were 
calculated for the duration of therapy using the tender prices from the National 
Department of Health and were related to treatment days.    
 
Initial antimicrobial use was evaluated using the parameters showed in Table 1. 
These prescribing markers and the patient¶VFOLQLFDOFRQGLWLRQZHUHGLVFXVVHGE\
the pharmacist with the treating physician or infectious diseases specialist during 
daily ward rounds. A collective decision was made by the health care team on the 
appropriate antimicrobial therapy and subsequently implemented. 
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Table 1: Antibiotic prescribing markers 
Drug factors Infectious biomarkers Patient factors 
x Dose 
x Duration of use 
x Indication of use 
x WBC count* 
x CRP** 
x Temperature 
x Blood culture 
x Procalcitonin 
x Diagnosis 
x Weight 
x Renal markers 
x Hepatic markers 
*WBC: White blood cell; CRP: **C-reactive protein 
 
Data were collected using a validated data collection instrument developed by the 
American Society of Hospital Pharmacists (American Society of Hospital 
Pharmacists, 1992). Over the years, the instrument had been used in multiple 
studies and further validated for use in the South African setting (Untiedt, 2004; 
Leteka, 2005; Baaisi, 2007; Schellack and Gous, 2010; Bronkhorst, 2012; 
Pretorius, 2012).  
 
Patients were followed for the duration of their initially prescribed antibiotic 
course. For example: Patient X is admitted to the MICU on amoxicillin, and 
VZLWFKHGLQWKHXQLWWRPHURSHQHP7KHDPR[LFLOOLQZDVUHFRUGHGDV³antibiotic 
SULRUWRUHYLHZ´ DQGPHURSHQHPDVWKH³LQLWLDOO\SUHVFULEHGDQWLELRWLF´ Patient 
X was then followed for the duration of meropenem therapy, e.g. either stopped 
or de-escalated. Laboratory data were obtained from the National Health 
Laboratory System (NHLS), providing services to the patients at SBAH. 
 
Statistical analysis 
Data ZHUHFDSWXUHGRQ0LFURVRIW([FHOVSUHDGVKHHWV DQGH[SRUWHG WR6$6® 
(SAS institute Inc. Cary, NC), Release 9.3 for statistical analysis, which was 
explorative and descriptive. Continuous variables were summarised by mean with 
standard deviation (SD), range with minimum and maximum values, and median 
with interquartile range (IQR). Categorical variables were summarised by 
frequency counts and percentage calculations.  
 
The initially-prescribed antibiotics were categorised and summarised 
descriptively. The GLUHFW FRVWV RI SDWLHQWV¶ LQLWLDO DQWLPLFURELDO XVDJH ZHUH
calculated according to the total daily dose and based on the tender prices of the 
National Department of Health for 2012. The cost for each item was derived from 
the following equation: Daily cost = (Antibiotic pack size x dosing interval) x days 
on antibiotics.  
 
Ethical considerations 
Ethical clearance for the study was obtained from the University of Pretoria 
(Number 178/2012) and the University of Limpopo, Medunsa Campus (Number 
MREC/H/212/2012: PG). As this was an observational study with review of 
patient records and no direct patient interaction, participant consent was not 
REWDLQHG  3DUWLFLSDQWV¶ SHUVRQDO LQIRUPDWLRQ ZDV RQO\ XVHG WR PDWFK WKH
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laboratory report obtained from the laboratory dataset with the dataset that is 
hosted at SBAH. Once this was done, no personal information was used further in 
the study.  
 
Results 
 
Patient demographics  
 
Of the 52 patients included during the study, slightly more were female (55.8%). 
The mean age was 40.1 years, ranging from 13 to 77 years, with one adolescent 
aged 13 years included in the study. The mean weight of the patients admitted to 
the study was 74.3 kg, with a range of 37 kg to 120 kg. Demographic 
characteristics are shown in Table 2.  
 
Table 2: Demographic characteristics  
Gender 
 
Female, n (%) 23 (44.2%) 
Male, n (%) 29 (55.8%) 
Age (years) Mean (SD) 40.1 (18.0) 
Range 13 - 77 
Median (IQR) 34 (26.5; 55.5) 
Weight (kg) Mean (SD) 74.3 (16.90) 
Range 37 - 120 
Median (IQR) 74.3 (65.0; 82.5) 
SD: Standard deviation; IQR: Interquartile range. 
 
Initiation of antibiotics 
Over the study period 76 antibiotics were initiated for the 52 patients. Nearly half 
of the patients 23 (44.2%) were initiated on antibiotics on day one of admission to 
the MICU. Twelve (23.1%) of the 52 patients were initiated on day two and five 
(9.6%) on day three. The remainder of the patients were initiated on day four (2%), 
day five (6%), day six (4%), day seven (8%) and day eight (2%). 
 
Of the 76 antibiotics prescribed initially, the majority 54 (71.1%) were started on 
the same day that the prior antibiotics were discontinued. Eight (10.5%) antibiotics 
were started one day after the prior antibiotics were stopped. The remainder of the 
WHQ SDWLHQWV¶ DQWLELRWLFV ZHUH VWDUWHG -12 days after the prior antibiotics were 
stopped.The majority of patients 42 (80.8%; n=52) were transferred from the 
wards to the ICU and 10 patients (19.2%) were admitted from home.  
 
Length of hospital stay (LOS) 
The median length of hospital stay (LOS) in the MICU for all patients was 10.50 
days (IQR: 6.0; 14.0) with a mean of 10.6 (SD: 4.9) days, ranging from 3 to 23 
days.  
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Antibiotics frequently prescribed and related costs 
During the study period 76 antibiotics were started for the 52 patients. Table 3 
illustrates the frequently prescribed antibiotics and costs associated with antibiotic 
use in the MICU. The three antibiotics most frequently prescribed during the study 
period were Meropenem, (19 times), Piperacillin/Tazobactam (10 times), and 
Clarithromycin (9 times).   
 
Table 3: Frequency and costs of antibiotics initiated in the MICU 
Anti-invectives for 
systemic use Numbe
r of 
patients 
(n=52) 
Mean 
days on 
antibiotic 
Mean total 
daily dose 
(g) 
Mean 
cost per 
day on 
antibiotic 
(R) 
Mean cost per 
treatment (R) ATC  
code 
INN of 
Antibiotic  
(n=16) 
J01D
H02 
Meropenem 19 
7.5 3.26 890.68 6 335.31 
J01C
R05 
Piperacillin/tazo
bactam  
10 
5.3 14.85 354.09 1 867.02 
J01F
A09 
Clarithromycin 9 
8.4 1 253.06 2 136.95 
J01X
X08 
Linezolid 5 
5.2 1.20 601.76 3 129.15 
J01D
D04 
Ceftriaxone 5 
5.4 2 45.12 243.65 
J01C
F02 
Cloxacillin 4 
6.0 11 193.16 1 229.20 
J01D
H51 
Imipenem 3 
6.7 3 762.96 5 001.63 
J01X
A02 
Teicoplanin 3 
6.7 0.80 299.26 1 995.07 
J01X
A01 
Vancomycin 3 
6.7 2 89.04 593.60 
J01C
R02 
Co-amoxiclav 6 
6.0 3.6 47.25 283.50 
J01E
E01 
Co-trimoxazole 2 
3.0 2.4 5.88 17.63 
J01G
B03 
Gentamicin 2 
5.5 0.18 7.11 42.62 
P01A
B01 
Metronidazole 2 
6.0 1.5 16.98 101.88 
J01D
D02 
Ceftazidime 1 
7.0 3 155.79 1 090.53 
J01F
F01 
Clindamycin 1 
5 1.8 36.96 184.80 
J01A
A12 
Tigecycline 1 
6 0.1 691.40 4 148.40 
Mean (SD) 
6.0 (1.2) 3.2 (4.0) 
278.16 
(298.01) 1 775.06 (1 949.56) 
Range 
3 - 8.4 0.1 ± 14.9 
5.88 - 
890.68 17.63 - 6 335.31 
Median (IQR) 
6 2 174.48 1 159.87 
ATC: Anatomical Therapeutic Chemical Classification System; INN: International Nonproprietary Name; 
SD: Standard Deviation; IQR: Interquartile Range 
 
In eight cases, Clarithromycin was used as part of dual therapy with either one of 
the following agents: i) Meropenem or Ceftriaxone for three patients; ii) 
Commented [AT1]: Ensure
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combination of Piperacillin/Tazobactam or Cloxacillin in two patients; iii) 
Vancomycin, Linezolid or Co-trimoxazole respectively as part of the combination 
for three patients. 
 
Total costs for initial antibiotic use 
As summarised in Table 3, the total costs for all initial antibiotics used during the 
study period were R209 140.40 and a cost of R4 021.9 per patient. The average 
cost of all initial antibiotics was R31 240.77 per day and R600.8 per patient day. 
The mean costs per treatment period for the three most frequently prescribed 
antibiotics were R63 35.31 for Meropenem, R1 867.02 for 
Piperacillin/Tazobactam, and R2 136.95 for Clarithromycin. 
 
Organ systems affected and diagnoses 
Figure 1 illustrates the different organ systems and disease states affected for the 
52 patients. In many cases, more than one organ system per patient were affected. 
(YLGHQWO\ µLQIHFWLRXV GLVHDVHV¶ were diagnosed most frequently, followed by 
diagnoses made related to the endocrine-metabolic, cardiovascular, renal and 
respiratory system. 
 
 
Figure 1: Organ systems and disease states affected. 
 
During the study period a total number of 167 diagnoses were made for the 52 
patients with an average of 3.2 diagnoses per patient. The most common diagnosis 
made during the study period was sepsis (11 times; 6.6%), followed by 
community-acquired pneumonia (CAP), hypertension and respiratory failure, 
which was eight times (4.8%) in each case.  
 
Number of antibiotics used during the hospital stay 
Overall, 76 antibiotics were prescribed for the 52 patients over the study period 
with an average of 1.4 antibiotics prescribed per patient. The antibiotics were 
prescribed according to the following classes:  
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x ȕ±lactams, 48 (63.2%): 
o Carbapenems, 22 (28.9%) 
o Penicillins, 20 (26.3%) 
o Cephalosporins, 6 (7.9%) 
x Macrolides, 9 (11.8%) 
x Glycopeptides, 6 (7.9%) 
x Oxazolidinones, 5 (6.6%) 
x Aminoglycosides, 2 (2.6%) 
x Trimethoprim/sulfamethoxazole, 2 (2.6%) 
x Metronidazole, 2 (2.6%) 
x Clindamycin, 1 (1.3%) 
x Tigecycline, 1 (1.3%) 
 
The majority of patients (38; 73.1%) were started in the MICU on one antibiotic, 
10 (19.2%) were started on two antibiotics, three (5.8%) were started on three 
antibiotics and one (1.9%) patient was started on four antibiotics (Ceftriaxone, 
Cloxacillin, Co-trimoxazole and Claritromycin). 
 
Inflammatory biomarkers 
Figure 2 illustrates the infection biomarkers (CRP, PCT, WBC and temperature) 
available for patients one day prior to initiation of initially-prescribed antibiotics 
(the day before antibiotics was prescribed). This is compared to the inflammatory 
biomarkers that were taken on the day of antibiotic initiation in the MICU. Not all 
of the biomarkers were available or recorded for the patients, and only the ones 
recorded in the file are displayed in Figure 2. 
 
 
Temp: Temperature; CRP: C-reactive protein; PCT: Procalcitonin: WBC: White blood cell 
Normal values: Temp: 37.0°C;  CRP: below 5mg/l : PCT: 0.00-0.05ng/ml: WBC: 3.92-9.88 109/l  
 
Figure 2: Inflammatory biomarkers prior to and on the day of antibiotic initiation in the 
MICU 
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Temperature: Almost a third of all patients (17; 32.7%) were admitted to the MICU with 
a mean prior temperature value of 37.2°C. Sixty percent (31) of the patients that were 
initiated on antibiotics in the MICU, had a slightly raised initial temperature with a mean 
value of 37.6°C. 
 
C-reactive protein (CRP): Nearly two thirds of the patients (32; 61.5%) were admitted to 
the MICU with a raised prior CRP and a mean value of 198.2mg/l (considered as above 
5mg/l). Almost all patients (51; 98.1 %), initiated on antibiotics in the MICU had a raised 
initial CRP with a mean value of 208.9mg/l. 
 
Procalcitonin (PCT): Nearly half of the patients (25, 48.1%), were admitted with an 
elevated prior PCT, with a mean value of 42.3ng/ml (considered as above 0.00-
0.05ng/ml). In the majority of the study population 46 (88.5%) the initial PCT was 
elevated on the day antibiotics were initiated with a mean value of 31.8ng/ml. 
 
White blood cell (WBC) count: Less than half of the patients (20; 38.5%) were admitted 
with a raised prior WBC count with a mean value of 11.9 109/l (considered as above 3.92-
9.88 109/l). For 31 patients (59.6%) the initial WBC count was elevated on the day 
antibiotics were initiated, with a mean value of 14.5 109/l. 
 
Microbiological cultures obtained 
A total number of 109 positive cultures were obtained during the study period. The 
number of positive cultures for all micro-organisms, according to specimen origin before 
or on the day when the initial antibiotic was prescribed, are illustrated in Figure 3.  
 
 
Figure 3: Number of positive cultures and specimen origin 
 
Of the cultures taken before the initially-prescribed antibiotic was started, 109 were 
positive, of which 64 were positive for bacteria. The remainder of the 45 positive 
organisms were of viral, fungal, mycobacterial and parasitic origin. Of the 64 positive 
cultures taken, 35 (54.7%) were from gram-negative bacilli and 19 (36.5%) were from 
gram-positive cocci.  Acinetobacter baumannii was cultured nine times.  
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Table 4 provides a summary of all micro-organisms cultured before and on the day the 
initially-prescribed antibiotic was started. For the majority of patients (43; 82.7%) cultures 
were taken prior to initiation of the antibiotics in the MICU. 
 
Table 4: Cultures prior to the initiation of initial antibiotics in the MICU 
Organism Frequency 
Gram negative  bacilli   
Acinetobacter baumannii 9 
Klebsiella pneumoniae 7 
Pseudomonas aeruginosa 7 
Enterobacter cloacae 6 
Citrobacter freundii 2 
Escherichia coli 1 
G negative bacillia 1 
Stenotrophomonas maltophilia 1 
Serratia 1 
    
Gram positive cocci   
Coagulase-negative staphylococci (CoNS) 9 
Staphylococcus epidermidis 3 
Methicillin-resistant Staphylococcus aureus (MRSA) 2 
Enterococcus faecalis 1 
Staphylococcus aureus 1 
Staphylococcus 1 
Streptococcus 1 
Vancomycin resistant enterococci (VRE) 1 
    
Gram negative  cocci   
G negative cocci 2 
    
Miscellaneous   
No growth 18 
Fastidious Antibiotic Neutralization Anaerobic 9 
G positive and G negative cocci  7 
 
Appropriate use of antibiotics 
Antibiotic use would be considered appropriate when evaluated according to the 
parameters as listed in Table 1. For example if it was the appropriate drug, at the 
right dose and for the right indication as specified in the South African Essential 
Medicines List at Hospital Level, (Standard Treatment Guidelines for Adults. 
1996) and if the patient had raised infectious biomarkers, and if the patient did not 
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have any risk factors (e.g. impaired renal function) for the use of the drug, then the 
antibiotic would be considered appropriate for the particular patents. 
 
Table 4 (continued): Cultures prior to the initiation of initial antibiotics in the MICU 
Organism Frequency 
Candida albicans 5 
No bacteria 3 
Cytomegalovirus positive 2 
Fastidious Antibiotic Neutralization Aerobic (FAN) 2 
Hepatitis B positive 2 
Negative acid-fast bacilli 2 
Bacteria observed 1 
H1N1 positive 1 
Malaria positive 1 
aNo specific strain was listed, reflected as stated on the laboratory report 
 
After the above parameters were taken into consideration by the pharmacist, and 
following consultation with the infectious diseases specialist, the results indicated 
that 46 (60.5%), of all initially-prescribed antibiotics in the MICU (n =76) were 
prescribed appropriately. Reasons for inappropriate antibiotic 30 (39.5%) use were 
as follows:  
 
x Three antibiotics were initiated in patients with normal inflammation 
biomarkers 
x Six antibiotics were initiated in patients with no positive cultures and no 
raised inflammation markers 
x Ten antibiotics were initiated for patients with no positive cultures  
x Eleven antibiotics were inappropriately prescribed according to the 
sensitivity patterns.  
 
Discussion  
 
The mean age of the patients admitted to the MICU and enrolled in this study was 
40.1 years, with females (55.8%) predominating slightly, which was in line with a 
similar study (Statistics South Africa. 2011; Song et al., 2013). This age group 
constitutes patients that are economically active in the society. 
 
The mean duration of hospital stay in this study was 10.6 days (range 3 to 23 days). 
This is in line with international (Wilke, Grube & Bodmann, 2011) and local 
literature as a similar study conducted at Groote Schuur Hospital in Cape Town, 
South Africa,also reported similar results with regards to length of hospital stay 
(Meyer, Smith & Mayosi, 2012). 
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The infection biomarkers obtained (WBC, CRP, PCT and temperature) for the 
patients in this study on admission to the MICU, were all raised and used to guide 
antibiotic use. Over the past two decades PCT, CRP, WBC have been extensively 
studied as serum markers of systemic infection and sepsis (Assink-de Jong et al., 
2013). The researchers further reported that PCT-guided therapy is not only 
beneficial for respiratory tract infections but also provide useful guidance for 
antimicrobial treatment in critically ill patients in the ICU who are treated for 
suspected bacterial infections. 
 
For half of the 52 patients, sepsis or an infective diagnosis was based on blood 
cultures. Specifically, positive ³VWHULOH VLWH´ cultures (such as blood cultures) 
better represent true infection than positive ³QRQ-VWHULOH VLWH´ cultures (such as 
wound and sputum cultures). Non-sterile sites are more likely to reflect 
colonization or contamination (Katsios et al., 2012). According to the Surviving 
Sepsis Campaign (2014), at least two sets of blood cultures (both aerobic and 
anaerobic bottles) should be obtained before antimicrobial therapy is initiated 
(Dellinger et al., 2012). 
 
The two antibiotics mostly prescribed, Meropenem and Pipericillin/Tazobactam, 
DUH ERWK PHPEHUV RI WKH ȕ±lactam group. A recent study conducted in 2012, 
VLPLODUO\ UHSRUWHG ȕ±lactams, including Carbapenems, as the most frequently 
prescribed antibiotics in empiric therapy for patients with severe sepsis and septic 
shock (Diaz-Martin et al., 2012).Meropenem was most frequently prescribed 
(25%; n=76) as initial antibiotic therapy for patients admitted to the MICU. This 
is in line with the Surviving Sepsis Campaign guidelines (2014) stating that a 
broad- spectrum antibiotic is indicated as first-line therapy in patients with sepsis 
(Dellinger et al., 2012). Furthermore it was also the most expensive first line 
therapy at a mean daily cost of R890.68. According to a study conducted in a large 
tertiary care academic medical centre, Meropenem was also the most expensive 
antibiotic (Standiford, Chan, Tripoli, Weekes & Forrest, 2012). Meropenem as 
first line therapy was approved by the infectious diseases specialist for patients 
with contributing co-morbidities that could lead to their demise before 
administration. 
 
Of the 52 patients included in the study, ten patients (19.2%) were prescribed 
Piperacillin/Tazobactam with an average daily cost of R354.09. In a study 
conducteGLQ6SDLQȕ-lactams are the mainstay of empiric therapy in patients with 
severe sepsis and septic shock (Diaz-Martin et al., 2012). The combination 
Piperacillin/Tazobactam was also used as empiric therapy for patients treated in 
an ICU setting with community acquired pneumonia (CAP) (Fariba, 2015). 
Empiric therapy should attempt to provide antimicrobial activity against the most 
OLNHO\SDWKRJHQVEDVHGXSRQHDFKSDWLHQW¶VSUHVHQWLQJLOOQHVVDQGORFDOSDWWHUQVRI
infection (Dellinger et al., 2012).Clarithromycin was mostly used as part of dual 
therapy in CAP. Clarithromycin is effective against commonly encountered 
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pathogens and is well tolerated (McCarthy, 2000). Azithromycin was not freely 
available in SBAH to use for CAP, and Clarithromycin was therefore used instead.  
A patient with CAP in an ICU setting will benefit from the addition of either 
Azithromycin or Clarithromycin (Fariba, 2015). 
 
In this study, 60.5% of antibiotics (n=76) were mostly prescribed appropriately, 
while 39.5% of antibiotics were prescribed inappropriately, according to weight, 
renal function (creatinine clearance), hepatic function, infection biomarkers (WBC 
count CRP, temperature, blood cultures and Procalcitonin). Antibiotic indication, 
dose and duration of treatment were compared to the Standard Treatment 
Guidelines and Essential Medicine List for Adults at Hospital Level and other 
relevant literature (National Department of Health, 1996). 
 
A multi-centre hospital-based study carried out in 2011, reported that 221 patients 
were identified with hospital acquired pneumonia (HAP) and ventilator-associated 
pneumonia (VAP), of whom approximately half (107; 48.4%) received adequate 
initial intravenous antibiotic therapy as opposed to 114 51.6%) who received 
inadequate initial intravenous antibiotic therapy (Song et al., 2013). A study that 
was conducted in 2012 on antibiotic prescription practices and their relationship 
to outcomes in South African intensive care units, revealed that therapeutic 
antibiotics were initiated in 182 patients, with more than half (54.9%) of them 
receiving inappropriate initial antibiotic therapy (Paruk et al., 2012). 
 
The total cost of initial antibiotic use during the study period was R209 140.40 
(R4021.90 per patient for the study period), with an average cost for all initial 
antibiotics during the study period of R31 240.77 (R600.80 average cost per 
patient during the study period).  No similar studies have been performed in any 
of the academic hospitals in South Africa to be able to compare rand values in 
terms of cost of initial antibiotic use in the ICU. However, a similar study that was 
conducted within a tertiary care academic medical center in the USA in 2012, 
reported higher costs of antibiotics, when compared to this study (Standiford et 
al., 2012). 
 
Conclusions 
 
From this study it was evident that WKHȕ-lactams were the mainstay of initially-
prescribed antimicrobial therapy in the MICU.The majority of initially-prescribed 
antibiotics were prescribed appropriately when considering drug factors, 
infectious biomarkers, costs, and patient factors, contrary to what is generally 
described in literature in terms of appropriateness of initially prescribed 
antibiotics. It is therefore, suggested that the presence of a clinical pharmacist and 
infectious diseases specialist, with the addition of an antibiotic policy and training 
might ensure continuous rational antibiotic use.  
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